Inactive Instrument

News AEterna Zentaris Inc. Nasdaq

Equities

CA0079753038

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 02	Mannatech Names James Clavijo Finance Chief	MT
Jun. 13	Aeterna Zentaris Inc. Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mannatech Names James Clavijo Finance Chief	Jul. 02	MT
Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	Jun. 13	AQ
Aeterna Zentaris Inc. Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	Jun. 13	CI
Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shortly	Jun. 03	MT
Aeterna Zentaris and Ceapro Complete Merger Transaction	Jun. 03	AQ
Aeterna Zentaris Inc. completed the acquisition of Ceapro Inc. in a merger of equals transaction.	Jun. 02	CI
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date	May. 29	AQ
Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger	May. 29	MT
Aeterna Zentaris Finalizes Some Details for Ceapro Merger	May. 17	MT
Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction with Ceapro	May. 17	MT
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro	May. 17	AQ
Aeterna Zentaris : Condensed Interim Consolidated Financial Statements As of March 31, 2024, and for the three months ended March 31, 2024, and 2023 - Form 6-K	May. 16	PU
Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K	May. 15	PU
MT Newswires Canada Overnight Stocks To Watch: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden	May. 14	MT
Aeterna Zentaris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Aeterna Zentaris Reports First Quarter 2024 Financial Results	May. 14	AQ
Aeterna Zentaris : MATERIAL CHANGE REPORT - Form 6-K	May. 09	PU
Reverse Split: 1 of 4	May. 02	FA
Aeterna Zentaris Announces Effective Date of Share Consolidation	May. 01	AQ
North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AEterna Zentaris Inc. Nasdaq

Equities

CA0079753038

Summary

Filters